UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review

Cell death & disease, 2019-12, Vol.10 (12), p.928-13, Article 928

2019

Volltextzugriff (PDF)

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1627-1640

2016

Volltextzugriff (PDF)

Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer

Cell death & disease, 2023-12, Vol.14 (12), p.823-823, Article 823

2023

Volltextzugriff (PDF)

Optimization of Advanced Live-Cell Imaging through Red/Near-Infrared Dye Labeling and Fluorescence Lifetime-Based Strategies

International journal of molecular sciences, 2021-10, Vol.22 (20), p.11092

2021

Volltextzugriff (PDF)

Centrosome, the Newly Identified Passenger through Tunneling Nanotubes, Increases Binucleation and Proliferation Marker in Receiving Cells

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9680

2021

Volltextzugriff (PDF)

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3573

2023

Volltextzugriff (PDF)

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

Journal of experimental & clinical cancer research, 2019-04, Vol.38 (1), p.158-158, Article 158

2019

Volltextzugriff (PDF)

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas

International journal of molecular sciences, 2022-05, Vol.23 (11), p.6042

2022

Volltextzugriff (PDF)

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

British journal of cancer, 2019-02, Vol.120 (4), p.387-397

2019

Volltextzugriff (PDF)

[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (8), p.1383-1392

2017

Volltextzugriff (PDF)

Syndecan 1 represses cell growth and FSH responsiveness in human granulosa cells

Reproduction (Cambridge, England), 2017-06, Vol.153 (6), p.797-808

2017

Volltextzugriff (PDF)

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

Targeted oncology, 2022-07, Vol.17 (4), p.407-431

2022

Volltextzugriff (PDF)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial

International journal of cancer, 2022-06, Vol.150 (11), p.1889-1904

2022

Volltextzugriff (PDF)

Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report

Heliyon, 2023-08, Vol.9 (8), p.e18420, Article e18420

2023

Volltextzugriff (PDF)

A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control

Cell communication and signaling, 2018-10, Vol.16 (1), p.66-20, Article 66

2018

Volltextzugriff (PDF)

Investigating Tunneling Nanotubes in Cancer Cells: Guidelines for Structural and Functional Studies through Cell Imaging

BioMed research international, 2020-04, Vol.2020, p.2701345-16

2020

Volltextzugriff (PDF)

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107287, Article 107287

2023

Volltextzugriff (PDF)

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

Journal of thoracic oncology, 2020-01, Vol.15 (1), p.120-124

2020

Volltextzugriff (PDF)

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway

Molecular cancer therapeutics, 2012-05, Vol.11 (5), p.1203-1213

2012

Volltextzugriff (PDF)

Alteration of cell membrane proteoglycans impairs FSH receptor/Gs coupling and ERK activation through PP2A-dependent mechanisms in immature rat Sertoli cells

Biochimica et biophysica acta, 2013-06, Vol.1830 (6), p.3466-3475

2013

Volltextzugriff (PDF)

An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial

Clinical cancer research, 2012-05, Vol.18 (10), p.2976-2986

2012

Volltextzugriff (PDF)

Combining sophisticated fast FLIM, confocal microscopy, and STED nanoscopy for live-cell imaging of tunneling nanotubes

Life science alliance, 2024-07, Vol.7 (7), p.e202302398

2024

Volltextzugriff (PDF)

O6‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation and low MGMT‐encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide

Cancer, 2012-09, Vol.118 (18), p.4545-4554

2012

Volltextzugriff (PDF)

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial

Cancers, 2019-11, Vol.11 (12), p.1835

2019

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(67)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer

Optimization of Advanced Live-Cell Imaging through Red/Near-Infrared Dye Labeling and Fluorescence Lifetime-Based Strategies

Centrosome, the Newly Identified Passenger through Tunneling Nanotubes, Increases Binucleation and Proliferation Marker in Receiving Cells

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

The Use of Pro-Angiogenic and/or Pro-Hypoxic miRNAs as Tools to Monitor Patients with Diffuse Gliomas

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

Syndecan 1 represses cell growth and FSH responsiveness in human granulosa cells

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial

Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report

A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

Investigating Tunneling Nanotubes in Cancer Cells: Guidelines for Structural and Functional Studies through Cell Imaging

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway

Alteration of cell membrane proteoglycans impairs FSH receptor/Gs coupling and ERK activation through PP2A-dependent mechanisms in immature rat Sertoli cells

An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial

Combining sophisticated fast FLIM, confocal microscopy, and STED nanoscopy for live-cell imaging of tunneling nanotubes

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial

Suchergebnisse filtern